Abbott (ABT) Reports Data Demonstrating Abbott's FreeStyle Libre 3 System is Most Accurate 14-Day Continuous Glucose Monitor

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. SPY
2. MDT
3. DELL
4. SPGI
5. USO
6. AAPL
7. ENOV
8. PANW
9. AON
10. NIO

Go back to Abbott (ABT) Reports Data Demonstrating Abbott's FreeStyle Libre 3 System is Most Accurate 14-Day Continuous Glucose Monitor

Late-Breaking Data Demonstrate Abbott's FreeStyle Libre® 3 System is Most Accurate 14-Day Continuous Glucose Monitor

June 5, 2022 9:00 AM EDT

Data at the American Diabetes Association 82nd Scientific Sessions show Abbott's FreeStyle Libre 3 system is first and only 14-day continuous glucose monitor (CGM) system to achieve a mean absolute relative difference (MARD) of less than 8%Additional data show the positive impact of the FreeStyle Libre system and LibreView app in helping healthcare professionals make earlier treatment decisions and detecting hypoglycemic events

ABBOTT PARK, Ill., June 5, 2022 /PRNewswire/ -- Abbott (NYSE: ABT) today announced late-breaking clinical data that... More